Langer Lab as Innovation Engine: Then, Now, Next
June 25, 2026
30DE
Type: Breakout Session
Focus Area:
Next Generation Biotherapeutics
Over the past five decades, the Langer Lab has played a central role in shaping modern biotechnology—founding more than 40 companies and training over 1,000 scientists, many of whom are now professors across ~400 institutions globally and have collectively launched hundreds of additional ventures.
What explains this level of sustained innovation and company creation—and can it be replicated?
In this discussion, Robert S. Langer, Michael Langer, and Alborz Madhavi will examine the principles behind this ecosystem—from cultivating curiosity and interdisciplinary thinking to consistently translating breakthrough science into capital-efficient companies.
The conversation will look forward, not just back—exploring how AI, new company creation models, and increasingly global networks are redefining the path from academic discovery to real-world impact.
Speakers
.jpeg)
Executive Chairman & Chair of Scientific Advisory Board, T.Rx Capital;
Institute Professor, Massachusetts Institute of Technology
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}